Literature DB >> 18287413

Differentiating cirrhosis and chronic hepatosplenic schistosomiasis using MRI.

Alexandre Sérgio de Araújo Bezerra1, Giuseppe D'Ippolito, Rogério P Caldana, Denise D Leopoldino, Giovani R Batista, Durval R Borges, Gaspar de Jesus Lopes Filho, Muneeb Ahmed.   

Abstract

OBJECTIVE: The objective of our study was to identify which imaging features may be used to differentiate between cirrhosis and chronic hepatosplenic schistosomiasis and to assess image interpretation agreement for MRI findings.
MATERIALS AND METHODS: Retrospective review of 27 patients with alcoholic or virus-induced cirrhosis and 24 patients with chronic hepatosplenic schistosomiasis who underwent MRI (1.5 T) of the abdomen was performed. Images were interpreted independently by two radiologists evaluating the following MRI features: hepatic fissure widening, irregularity of hepatic contours, periportal fibrosis, hepatic parenchyma heterogeneity, and splenic siderotic nodules. Left, right, and caudate hepatic lobe measurements were obtained, and the splenic index was measured. The Fisher's exact test, chi-square test, and Student's t test were used to compare both groups, and regression analysis was performed. Observer agreement was measured using kappa and intraclass correlation tests.
RESULTS: Periportal fibrosis, heterogeneity of hepatic parenchyma, and splenic siderotic nodules were more frequent in the group with schistosomiasis (p < 0.05), with periportal fibrosis showing the largest difference in presence and distribution (peripheral greater than central). The transverse diameter of the right hepatic lobe, caudate lobe-right lobe ratio, and splenic index were larger in patients with chronic schistosomiasis (p < 0.001). At multiple regression analysis, splenic siderotic nodules, splenic index, and caudate lobe-right lobe ratio were predictive of schistosomiasis. Observer agreement was substantial or almost perfect for almost all variables analyzed (kappa or r = 0.81-1.00).
CONCLUSION: The presence of peripheral periportal fibrosis, heterogeneity of hepatic parenchyma, and splenic siderotic nodules, and the splenic index and caudate lobe-right lobe ratio are useful features for differentiating alcoholic or virus-induced cirrhosis from chronic schistosomiasis using MRI.

Entities:  

Mesh:

Year:  2008        PMID: 18287413     DOI: 10.2214/AJR.07.2639

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Ultrasonography of gallbladder abnormalities due to schistosomiasis.

Authors:  Joachim Richter; Daniel Azoulay; Yi Dong; Martha C Holtfreter; Robert Akpata; Julien Calderaro; Tarik El-Scheich; Matthias Breuer; Andreas Neumayr; Christoph Hatz; Gerald Kircheis; Monica C Botelho; Christoph F Dietrich
Journal:  Parasitol Res       Date:  2016-05-12       Impact factor: 2.289

Review 2.  Other types of diffuse liver disease: is there a way to do it?

Authors:  Hilton Leao Filho; Camila Vilela de Oliveira; Natally Horvat
Journal:  Abdom Radiol (NY)       Date:  2020-11

3.  Increased IL-17, a Pathogenic Link between Hepatosplenic Schistosomiasis and Amyotrophic Lateral Sclerosis: A Hypothesis.

Authors:  Oswald Moling; Alfonsina Di Summa; Loredana Capone; Josef Stuefer; Andrea Piccin; Alessandra Porzia; Antonella Capozzi; Maurizio Sorice; Raffaella Binazzi; Lathá Gandini; Giovanni Rimenti; Peter Mian
Journal:  Case Reports Immunol       Date:  2014-07-23

4.  Imaging findings of hepatosplenic schistosomiasis: a case report.

Authors:  Sabriye Sennur Bilgin; Huseyin Toprak; Mehmet Seker
Journal:  Radiol Case Rep       Date:  2016-06-21

5.  Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis.

Authors:  Takahiko Fukuchi; Hitoshi Sugawara
Journal:  Intern Med       Date:  2019-11-22       Impact factor: 1.271

6.  Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: A Prospective Cohort Study.

Authors:  Edford Sinkala; Michael Vinikoor; Kanekwa Zyambo; Ellen Besa; Bright Nsokolo; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.